762 related articles for article (PubMed ID: 22277193)
21. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.
Juretzka MM; Barakat RR; Chi DS; Iasonos A; Dupont J; Abu-Rustum NR; Poynor EA; Aghajanian C; Spriggs D; Hensley ML; Sabbatini P
Gynecol Oncol; 2007 Jan; 104(1):176-80. PubMed ID: 16996584
[TBL] [Abstract][Full Text] [Related]
22. ErbB-3 predicts survival in ovarian cancer.
Tanner B; Hasenclever D; Stern K; Schormann W; Bezler M; Hermes M; Brulport M; Bauer A; Schiffer IB; Gebhard S; Schmidt M; Steiner E; Sehouli J; Edelmann J; Läuter J; Lessig R; Krishnamurthi K; Ullrich A; Hengstler JG
J Clin Oncol; 2006 Sep; 24(26):4317-23. PubMed ID: 16896008
[TBL] [Abstract][Full Text] [Related]
23. Functional role and prognostic significance of CD157 in ovarian carcinoma.
Ortolan E; Arisio R; Morone S; Bovino P; Lo-Buono N; Nacci G; Parrotta R; Katsaros D; Rapa I; Migliaretti G; Ferrero E; Volante M; Funaro A
J Natl Cancer Inst; 2010 Aug; 102(15):1160-77. PubMed ID: 20639476
[TBL] [Abstract][Full Text] [Related]
24. Human kallikrein related peptidases 6 and 13 in combination withCA125 is a more sensitive test for ovarian cancer than CA125 alone.
White NM; Mathews M; Yousef GM; Prizada A; Fontaine D; Ghatage P; Popadiuk C; Dawson L; Doré JJ
Cancer Biomark; 2009; 5(6):279-87. PubMed ID: 20037204
[TBL] [Abstract][Full Text] [Related]
25. Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells.
Okamoto A; Nikaido T; Ochiai K; Takakura S; Saito M; Aoki Y; Ishii N; Yanaihara N; Yamada K; Takikawa O; Kawaguchi R; Isonishi S; Tanaka T; Urashima M
Clin Cancer Res; 2005 Aug; 11(16):6030-9. PubMed ID: 16115948
[TBL] [Abstract][Full Text] [Related]
26. Prognostic DNA methylation biomarkers in ovarian cancer.
Wei SH; Balch C; Paik HH; Kim YS; Baldwin RL; Liyanarachchi S; Li L; Wang Z; Wan JC; Davuluri RV; Karlan BY; Gifford G; Brown R; Kim S; Huang TH; Nephew KP
Clin Cancer Res; 2006 May; 12(9):2788-94. PubMed ID: 16675572
[TBL] [Abstract][Full Text] [Related]
27. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
28. Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis.
Yoshihara K; Tajima A; Komata D; Yamamoto T; Kodama S; Fujiwara H; Suzuki M; Onishi Y; Hatae M; Sueyoshi K; Fujiwara H; Kudo Y; Inoue I; Tanaka K
Cancer Sci; 2009 Aug; 100(8):1421-8. PubMed ID: 19486012
[TBL] [Abstract][Full Text] [Related]
29. Human leukocyte antigen class I antigen expression is an independent prognostic factor in ovarian cancer.
Rolland P; Deen S; Scott I; Durrant L; Spendlove I
Clin Cancer Res; 2007 Jun; 13(12):3591-6. PubMed ID: 17575223
[TBL] [Abstract][Full Text] [Related]
30. 14-3-3sigma expression and prognostic value in patients with epithelial ovarian carcinoma: a high throughput tissue microarray analysis.
Mhawech-Fauceglia P; Herrmann FR; Andrews C; South S; Beck A; Lele S; Odunsi K
Eur J Surg Oncol; 2009 Jul; 35(7):763-7. PubMed ID: 19081223
[TBL] [Abstract][Full Text] [Related]
31. Gene expression meta-analysis identifies chromosomal regions involved in ovarian cancer survival.
Thomassen M; Jochumsen KM; Mogensen O; Tan Q; Kruse TA
Genes Chromosomes Cancer; 2009 Aug; 48(8):711-24. PubMed ID: 19441089
[TBL] [Abstract][Full Text] [Related]
32. A prognostic 11 genes expression model for ovarian cancer.
Men CD; Liu QN; Ren Q
J Cell Biochem; 2018 Feb; 119(2):1971-1978. PubMed ID: 28817186
[TBL] [Abstract][Full Text] [Related]
33. Discovery of microarray-identified genes associated with ovarian cancer progression.
Liu X; Gao Y; Zhao B; Li X; Lu Y; Zhang J; Li D; Li L; Yin F
Int J Oncol; 2015; 46(6):2467-78. PubMed ID: 25891226
[TBL] [Abstract][Full Text] [Related]
34. Bioinformatics analysis to screen the key prognostic genes in ovarian cancer.
Li L; Cai S; Liu S; Feng H; Zhang J
J Ovarian Res; 2017 Apr; 10(1):27. PubMed ID: 28407786
[TBL] [Abstract][Full Text] [Related]
35. Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array.
Vathipadiekal V; Wang V; Wei W; Waldron L; Drapkin R; Gillette M; Skates S; Birrer M
Clin Cancer Res; 2015 Nov; 21(21):4960-9. PubMed ID: 25944803
[TBL] [Abstract][Full Text] [Related]
36. Identifying prognostic signature in ovarian cancer using DirGenerank.
Wang JY; Chen LL; Zhou XH
Oncotarget; 2017 Jul; 8(28):46398-46413. PubMed ID: 28615526
[TBL] [Abstract][Full Text] [Related]
37. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer.
Győrffy B; Surowiak P; Budczies J; Lánczky A
PLoS One; 2013; 8(12):e82241. PubMed ID: 24367507
[TBL] [Abstract][Full Text] [Related]
38. Cross-validation of genes potentially associated with overall survival and drug resistance in ovarian cancer.
Gao Y; Liu X; Li T; Wei L; Yang A; Lu Y; Zhang J; Li L; Wang S; Yin F
Oncol Rep; 2017 May; 37(5):3084-3092. PubMed ID: 28350120
[TBL] [Abstract][Full Text] [Related]
39. Quality Control Usage in High-Density Microarrays Reveals Differential Gene Expression Profiles in Ovarian Cancer.
Villegas-Ruiz V; Moreno J; Jacome-Lopez K; Zentella-Dehesa A; Juarez-Mendez S
Asian Pac J Cancer Prev; 2016; 17(5):2519-25. PubMed ID: 27268623
[TBL] [Abstract][Full Text] [Related]
40. Clinical relevance of cytoskeleton associated proteins for ovarian cancer.
Schiewek J; Schumacher U; Lange T; Joosse SA; Wikman H; Pantel K; Mikhaylova M; Kneussel M; Linder S; Schmalfeldt B; Oliveira-Ferrer L; Windhorst S
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2195-2205. PubMed ID: 30094535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
